SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-21-007456
Filing Date
2021-07-19
Accepted
2021-07-19 16:06:25
Documents
12
Period of Report
2021-07-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_071621.htm   iXBRL 8-K 28851
  Complete submission text file 0001387131-21-007456.txt   201021

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE admp-20210716.xsd EX-101.SCH 2999
3 XBRL PRESENTATION FILE admp-20210716_pre.xml EX-101.PRE 22341
4 XBRL LABEL FILE admp-20210716_lab.xml EX-101.LAB 34238
5 EXTRACTED XBRL INSTANCE DOCUMENT admp-8k_071621_htm.xml XML 3589
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 211097975
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences